Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued on Friday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright decreased their price target on shares of Aethlon Medical from $23.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, March 4th.

Aethlon Medical Stock Performance

Shares of AEMD stock opened at $0.59 on Friday. The firm has a market cap of $1.54 million, a price-to-earnings ratio of -0.12 and a beta of 1.60. Aethlon Medical has a 52 week low of $0.37 and a 52 week high of $5.00. The firm’s 50-day simple moving average is $1.08 and its two-hundred day simple moving average is $1.57.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.